Trial for HPV16 positive oropharyngeal cancer completes enrolment for phase 2
Netherlands-based ISA Pharmaceuticals B.V., has announced that it has completed enrolment in its phase 2…
December 1, 2022 - 2 minutes
Regeneron
Prurigo nodularis treatment recommended for EU approval
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has adopted a…
November 11, 2022 - 3 minutes
Late-breaking data shows significant remission in children with EoE
Late-breaking positive results from a phase 3 trial have shown that children with eosinophilic esophagitis…
October 11, 2022 - 3 minutes
Treatment for adults with chronic skin condition approved by FDA
The U.S. Food and Drug Administration (FDA) has approved Dupixent (dupilumab) for the treatment of…
September 29, 2022 - 4 minutes
Regeneron and Sanofi announce published trial results in children with dermatitis
Positive results from a phase 3 trial in children aged 6 months to five years…
September 16, 2022 - 3 minutes
Improved vision with less eye injections for patients after primary endpoints met in trials
The primary endpoints in two clinical trials investigating drug aflibercept 8 mg with 12 and…
September 9, 2022 - 3 minutes
OncoResponse and Regeneron to evaluate drug combo for patients with advanced cancer
OncoResponse, a clinical-stage biotech company advancing immunotherapies derived from the immune systems of elite cancer…
September 7, 2022 - 2 minutes
Kymab Wins UK Supreme Court Antibody Battle Against Regeneron
The UK Supreme Court has supported an appeal by British biotech Kymab to revoke antibody…
June 30, 2020 - 4 minutes
Update: Fifth US Antibody Patent Owned by UK Biotech Upheld in Regeneron Battle
Update (04/06/2020): After upholding four of Kymab's patents addressing the production of antibody drugs earlier…
June 4, 2020 - 4 minutes
Finnish Genetics Study Provides Clues for Treating Type 2 Diabetes
A genetic mutation common to Finnish populations has been found to protect against type 2…
November 4, 2019 - 2 minutes
Dutch and US Biotechs Team Up Against HPV-related Cancer
ISA Pharmaceuticals will work together with Regeneron to combine its immunotherapy against cancer induced by…
December 18, 2017 - 2 minutes
Biotech and Pharma Giants Make a Good Start to Phase II Trial for Skin Cancer
Regeneron and Sanofi have announced positive early results from a Phase II study investigating their…
December 13, 2017 - 3 minutes
